Erlotinib intermediates manufacturer

Tel: +86-311-67260775


Nintedanib is the first FDA-approved drug for the management of idiopathic pulmonary fibrosis (IPF), a rare but often fatal lung disease. Nintedanib is believed to exert its mechanism of action by inhibiting multiple receptor tyrosine kinases, including those that have been implicated in the pathogenesis of IPF (i.e., fibroblast growth factor receptor, platelet-derived growth factor receptor, and vascular endothelial growth factor receptor). Nintedanib also inhibits nonreceptor tyrosine kinases, although the contribution of this inhibition in the efficacy of the drug is unknown.


Product name: Nintedanib

Cas No.: 656247-17-5

Einecs No.: 1592732-453-0

MF: C31H33N5O4

Purity: 99%

Test Specification Result
Nintedanib Appearance Off-white powder Conforms
Moisture ≤1.5% 0.15%
Assay(By HPLC) ≥99.0% 99.5%
Storage Store in a tightly closed container in a cool and dry place, below 20℃.
Conclusion Confirm to enterprise standard


Nintedanib function is antiinflammatory and antifibrotic agent that is used to treat idiopathic pulmonary fibrosis.

Antiinflammatory and anti fibrotic agent that is used to treat idiopathic pulmonary fibrosis.


Nintedanib typical application area: Applied in pharmaceutical field.

Packaging Details

25kgs packaging Fiber drum outside and plastic bag inside 1-25kgs packaging aluminium bag outside and double plastic bag inside

Delivery Detail: within 3 days when get the payment


We have Professional shipping agent, based on customers ' demand for transport

By express :FEDEX,DHL,EMS ,UPS,TNT ect.

By SEA and By AIR

Send your message to us
(* We will reply your inquiry to this Email as soon as we see it.)
Name: *
E-mail: *
Message: *
Verification Code: *图片看不清?点击重新得到验证码
Other Products
Office Address: No.41, Zhaiying South Street, Yuhua District, Shijiazhuang, Hebei Province.Chinaa
R&D and Plant Address: Jinzhou Industry Park, Jinzhou County, Shijizhuang, Hebei Province.China
Tel: +86-311-67260775
Fax: +86-311-67591193
Online Service×